KORU Medical Systems Gross Margin 2010-2025 | KRMD
Current and historical gross margin for KORU Medical Systems (KRMD) over the last 10 years. The current gross profit margin for KORU Medical Systems as of March 31, 2025 is %.
| KORU Medical Systems Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $0.04B | $0.02B | 62.86% |
| 2024-12-31 | $0.03B | $0.02B | 63.64% |
| 2024-09-30 | $0.03B | $0.02B | 61.29% |
| 2024-06-30 | $0.03B | $0.02B | 60.00% |
| 2024-03-31 | $0.03B | $0.02B | 58.62% |
| 2023-12-31 | $0.03B | $0.02B | 57.14% |
| 2023-09-30 | $0.03B | $0.02B | 57.14% |
| 2023-06-30 | $0.03B | $0.02B | 55.17% |
| 2023-03-31 | $0.03B | $0.02B | 51.72% |
| 2022-12-31 | $0.03B | $0.02B | 53.57% |
| 2022-09-30 | $0.03B | $0.02B | 55.56% |
| 2022-06-30 | $0.03B | $0.01B | 56.00% |
| 2022-03-31 | $0.02B | $0.01B | 58.33% |
| 2021-12-31 | $0.02B | $0.01B | 56.52% |
| 2021-09-30 | $0.02B | $0.01B | 52.38% |
| 2021-06-30 | $0.02B | $0.01B | 57.14% |
| 2021-03-31 | $0.02B | $0.01B | 60.87% |
| 2020-12-31 | $0.02B | $0.02B | 62.50% |
| 2020-09-30 | $0.03B | $0.02B | 65.38% |
| 2020-06-30 | $0.03B | $0.02B | 62.96% |
| 2020-03-31 | $0.02B | $0.02B | 62.50% |
| 2019-12-31 | $0.02B | $0.01B | 60.87% |
| 2019-09-30 | $0.02B | $0.01B | 61.90% |
| 2019-06-30 | $0.02B | $0.01B | 63.16% |
| 2019-03-31 | $0.02B | $0.01B | 63.16% |
| 2018-12-31 | $0.02B | $0.01B | 61.11% |
| 2018-09-30 | $0.02B | $0.01B | 56.25% |
| 2018-06-30 | $0.02B | $0.01B | 53.33% |
| 2018-03-31 | $0.01B | $0.01B | 50.00% |
| 2017-12-31 | $0.01B | $0.01B | 50.00% |
| 2017-06-30 | $0.01B | $0.01B | 54.55% |
| 2017-03-31 | $0.01B | $0.01B | 60.00% |
| 2016-11-30 | $0.01B | $0.01B | 66.67% |
| 2016-09-30 | $0.01B | $0.01B | 66.67% |
| 2016-06-30 | $0.01B | $0.01B | 66.67% |
| 2016-05-31 | $0.01B | $0.01B | 66.67% |
| 2015-08-31 | $0.01B | $0.01B | 66.67% |
| 2015-05-31 | $0.01B | $0.01B | 66.67% |
| 2014-08-31 | $0.01B | $0.01B | 62.50% |
| 2014-05-31 | $0.01B | $0.00B | 57.14% |
| 2013-08-31 | $0.01B | $0.00B | 50.00% |
| 2013-05-31 | $0.01B | $0.00B | 50.00% |
| 2012-05-31 | $0.00B | $0.00B | 50.00% |
| 2011-12-31 | $0.01B | $0.00B | 60.00% |
| 2010-06-30 | $0.00B | $0.00B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.161B | $0.034B |
| KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.883B | 59.65 |
| Hims & Hers Health (HIMS) | United States | $14.668B | 152.40 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Tempus AI (TEM) | United States | $10.008B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.472B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.870B | 60.47 |
| Hinge Health (HNGE) | United States | $3.513B | 0.00 |
| Privia Health (PRVA) | United States | $2.388B | 163.25 |
| 10x Genomics (TXG) | United States | $1.713B | 0.00 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Enovis (ENOV) | United States | $1.544B | 8.61 |
| Azenta (AZTA) | United States | $1.530B | 71.11 |
| Schrodinger (SDGR) | United States | $1.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.476B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 24.55 |
| Evolent Health (EVH) | United States | $1.162B | 99.00 |
| Claritev (CTEV) | United States | $0.636B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.532B | 0.00 |
| Standard BioTools (LAB) | United States | $0.524B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| TruBridge (TBRG) | United States | $0.315B | 698.67 |
| Outset Medical (OM) | United States | $0.300B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.175B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.077B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |